Latest Events
- Pharmaceutical Outsourcing Interview:
An interview with ResearchDx in Pharmaceutical Outsourcing
www.pharmoutsourcing.com - June 2012:
ResearchDx executives featured in June issue of Drug Development and Delivery
- Frost and Sullivan Award:
ResearchDx is the proud recipient of the prestigious Frost and Sullivan Award for Outstanding Performance in the Companion Diagnostics Sector
F&S Press Release - 2013 BioPharma Asia:
ResearchDx Sponsored and presented at BioPharma Asia 2013
BioPharma Asia 2013 - Next Generation Sequencing Services:
ResearchDx now offers Next Generation Sequencing (NGS) services in our CLIA and clinical research divisions.
Whole Genome Sequencing
Exome Sequencing
Targeted Resequencing
RNA-Seq
ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. We provide integrated, turn-key, flexible services that are focused on our customers’ objectives. We manage the entire diagnostic development process – from initial assay concept and discovery through clinical research to regulatory approval. At ResearchDx, we take contract R&D for diagnostics to the next generation.

Trust ResearchDx to stay on track
Integrated
services
ResearchDx provides independent and unbiased guidance, expert analysis and seamless integration of all the services you need to develop a diagnostic product including; assay development, clinical laboratory services, clinical trial design and conduct, project management, manufacturing, regulatory guidance and submissions, and consulting

Flexibility
ResearchDx can adapt to meet your complex and constantly evolving needs for diagnostic development. We can build, validate, and perform any assay that your business demands, or alternatively work with competing technology vendors to ensure the best fit for your application.
Focus on
your business
Your diagnostic development is ResearchDx’s sole focus. We have the experience and dedication to ensure the fastest possible path to commercialization and regulatory approval of the diagnostic product.









